Ross GD - Search Results

1

CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions.

Ross GD, Vĕtvicka V. Ross GD, et al. Clin Exp Immunol. 1993 May;92(2):181-4. doi: 10.1111/j.1365-2249.1993.tb03377.x. Clin Exp Immunol. 1993. PMID: 8485905 Free PMC article. Review.

2

Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).

Thornton BP, Vĕtvicka V, Pitman M, Goldman RC, Ross GD. Thornton BP, et al. Among authors: ross gd. J Immunol. 1996 Feb 1;156(3):1235-46. J Immunol. 1996. PMID: 8558003

3

Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.

Vetvicka V, Thornton BP, Ross GD. Vetvicka V, et al. Among authors: ross gd. J Clin Invest. 1996 Jul 1;98(1):50-61. doi: 10.1172/JCI118777. J Clin Invest. 1996. PMID: 8690804 Free PMC article.

4

Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells.

Thornton BP, Vetvicka V, Ross GD. Thornton BP, et al. Among authors: ross gd. Clin Exp Immunol. 1996 Jun;104(3):531-7. doi: 10.1046/j.1365-2249.1996.57761.x. Clin Exp Immunol. 1996. PMID: 9099940 Free PMC article.

5

Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18).

Vetvicka V, Thornton BP, Wieman TJ, Ross GD. Vetvicka V, et al. Among authors: ross gd. J Immunol. 1997 Jul 15;159(2):599-605. J Immunol. 1997. PMID: 9218574

6

Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.

Vĕtvicka V, Hanikýrová M, Vĕtvicková J, Ross GD. Vĕtvicka V, et al. Among authors: ross gd. Clin Exp Immunol. 1999 Feb;115(2):229-35. doi: 10.1046/j.1365-2249.1999.00800.x. Clin Exp Immunol. 1999. PMID: 9933447 Free PMC article.

7

The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.

Xia Y, Vetvicka V, Yan J, Hanikýrová M, Mayadas T, Ross GD. Xia Y, et al. Among authors: ross gd. J Immunol. 1999 Feb 15;162(4):2281-90. J Immunol. 1999. PMID: 9973505

8

Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).

Yan J, Vetvicka V, Xia Y, Coxon A, Carroll MC, Mayadas TN, Ross GD. Yan J, et al. Among authors: ross gd. J Immunol. 1999 Sep 15;163(6):3045-52. J Immunol. 1999. PMID: 10477568

9

Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan.

Yan J, Vetvicka V, Xia Y, Hanikýrová M, Mayadas TN, Ross GD. Yan J, et al. Among authors: ross gd. Immunopharmacology. 2000 Jan;46(1):39-54. doi: 10.1016/s0162-3109(99)00157-5. Immunopharmacology. 2000. PMID: 10665778

10

CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents.

Muto S, Vĕtvicka V, Ross GD. Muto S, et al. Among authors: ross gd. J Clin Immunol. 1993 May;13(3):175-84. doi: 10.1007/BF00919970. J Clin Immunol. 1993. PMID: 8100571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters